Upon completion of this activity, participants will be able to:1. Discuss the epidemiology of PE and clinical impact of PERT models for delivery of PE care.2. Describe the available suite of endovascular modalities currently used for PE treatment.3. Manipulate devices to treat PE focusing on practical techniques and best practices for endovascular management of submassive and massive PE patients.4. Examine approaches for building local PERT programs in various health system settings.
Individuals in control of content reported the following relevant financial relationships with ineligible companiesduring the content development process for this activity. All relevant financial relationships were mitigated beforethe start of the activity. PlannersCatalin Toma: Consulting with Jupiter Endovascular. Advisory Board with Inari Medical.
Michael Young: Consulting with Edwards Lifesciences. Consulting with Boston Scientific Corp.
FacultyVikas Aggarwal: Consulting with Jupiter endovascular.
Sripal Bangalore: Advisory Board with Abbott Vascular. Advisory Board with Boston Scientific.
Jay Giri: Advisory Board with Boston Scientific Corp. Advisory Board with Edwards Lifesciences. Advisory Board and PI with Inari/Stryker.
Wissam Jaber: Consulting with Medtronic. Advisory Board with Inari. Advisory Board with Thrombolex. Advisory Board with Inquis. Advisory Board with Jupiter. Consulting with Abbott.
Jun Li: Consulting with Abbott. Consulting with Medtronic. Consulting with Boston Scientific Corp. Consulting with Inari Medical. Consulting with Inquis Medical.
Andrew Klein: No financial relationships with ineligible companies.
Sanjum Sethi: Consulting and Speaker, honoraria with Boston Scientific Corp. Speaker, honoraria with Chiesi. Speaker, honoraria with Janssen. Speaker, honoraria with Terumo. Speaker, honoraria with Inari. Speaker, honoraria with Penumbra.
Reviewer Andrew Klein: No relevant financial relationships with ineligible companies.
SCAI Staff Laura Porter: No relevant financial relationships with ineligible companies.
Accreditation StatementThe Society for Cardiovascular Angiography and Interventions (SCAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit DesignationSCAI designates this enduring material for a maximum of 3.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOCSuccessful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to 3.75 MOC point in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABIM MOC credit.
Successful CompletionWatch the content and complete the evaluation to obtain credit.